Search

Search Constraints

You searched for: Author/Creator Ast, Oliver

Search Results

1. A long-lived IL-2 mutein that selectively activates and expands regulatory T cells as a therapy for autoimmune disease. (December 2018)

2. ITOC2 – 037. CEA TCB, A novel T-cell bispecific antibody with potent in vitro and in vivo antitumour activity against solid tumours. (March 2015)

3. Cergutuzumab amunaleukin (CEA-IL2v), a CEA-targeted IL-2 variant-based immunocytokine for combination cancer immunotherapy: Overcoming limitations of aldesleukin and conventional IL-2-based immunocytokines. (4th March 2017)

4. Sustained in vivo signaling by long-lived IL-2 induces prolonged increases of regulatory T cells. (January 2015)